Tumor infiltrating CD8+T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

(2014) M. V. Dieci et al.   ANNALS OF ONCOLOGY

Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type

(2014) Z. Gatalica et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity

(2013) Sylvain Ladoire et al.   ANTIOXIDANTS & REDOX SIGNALING

DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells

(2013) Johanna Tuomela et al.   BREAST CANCER RESEARCH AND TREATMENT

New Insights into the Role of the Immune Microenvironment in Breast Carcinoma

(2013) Luis de la Cruz-Merino et al.   Clinical & Developmental Immunology

Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs

(2013) B. Allard et al.   CLINICAL CANCER RESEARCH

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells

(2013) Yuting Ma et al.   IMMUNITY

Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast

(2013) MM Goel et al.   INDIAN JOURNAL OF CANCER

Diagnostic and Therapeutic Implications of Tumor-Infiltrating Lymphocytes in Breast Cancer

(2013) Carsten Denkert   JOURNAL OF CLINICAL ONCOLOGY

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

(2013) Sherene Loi et al.   JOURNAL OF CLINICAL ONCOLOGY

At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

(2013) Margaret K. Callahan et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer

(2013) MARJA-RIITTA VÄISÄNEN et al.   Oncology Letters

Immunogenic cell death in radiation therapy

(2013) Lorenzo Galluzzi et al.   OncoImmunology

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

(2013) Sherene Loi   OncoImmunology

Immunogenic Cell Death in Cancer Therapy

(2012) Guido Kroemer et al.   Annual Review of Immunology

Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer

(2012) Johanna Tuomela et al.   BREAST CANCER RESEARCH AND TREATMENT

Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients

(2012) Naofumi Oda et al.   BREAST CANCER RESEARCH AND TREATMENT

Therapeutic Implications of KIT in Melanoma

(2012) Michael A. Postow et al.   CANCER JOURNAL

Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer

(2012) F. Andre et al.   CLINICAL CANCER RESEARCH

Triple Negative Breast Cancer: From Molecular Portrait to Therapeutic Intervention

(2012) Pietro Carotenuto et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

High DGK-  and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention

(2012) P. U. Prinz et al.   JOURNAL OF IMMUNOLOGY

An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer

(2012) Juha P. Väyrynen et al.   VIRCHOWS ARCHIV

Intratumoral alterations of dendritic-cell differentiation and CD8+T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma

(2012) Elfriede Noessner et al.   OncoImmunology

Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response

(2011) J. Fucikova et al.   CANCER RESEARCH

Bridging Innate and Adaptive Immunity

(2011) William E. Paul   CELL

Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma

(2011) Joonas H Kauppila et al.   HISTOPATHOLOGY

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

(2011) Sahar M.A. Mahmoud et al.   JOURNAL OF CLINICAL ONCOLOGY

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

(2011) Hanna Ronkainen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Toll-Like Receptor 9 Is a Novel Biomarker for Esophageal Squamous Cell Dysplasia and Squamous Cell Carcinoma Progression

(2011) Heikki Takala et al.   Journal of Innate Immunity

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

(2011) Sylvain Ladoire et al.   JOURNAL OF PATHOLOGY

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

(2010) Regina Berger et al.   CANCER SCIENCE

Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13

(2010) S. Nurmenniemi et al.   EXPERIMENTAL CELL RESEARCH

JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation inCD8+T Cells in Renal Cell Carcinoma Patients

(2010) Elisabetta Cavalcanti et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors

(2010) Marja-Riitta Väisänen et al.   PROSTATE

The immunogenicity of tumor cell death

(2008) Oliver Kepp et al.   CURRENT OPINION IN ONCOLOGY

Toll-Like Receptor-9 Expression Is Inversely Correlated with Estrogen Receptor Status in Breast Cancer

(2008) Arja Jukkola-Vuorinen et al.   Journal of Innate Immunity

Expression of TLR9 within human glioblastoma

(2008) Yuxia Meng et al.   JOURNAL OF NEURO-ONCOLOGY

Increased expression of Toll-like receptors 4 and 9 in human lung cancer

(2008) Yan-Bei Zhang et al.   MOLECULAR BIOLOGY REPORTS

Toll-Like Receptor 9 Mediates CpG Oligonucleotide-Induced Cellular Invasion

(2008) J. M. Ilvesaro et al.   MOLECULAR CANCER RESEARCH